Showing results (141-150 of 220) with videos related to

Sort By:
Pageof 22
Clinical Therapeutics|November 26, 1998
Advances in the management of Crohn's disease: economic and clinical potential of infliximabS B Hanauer, R D Cohen, R V Becker, et al.
Alimentary Pharmacology & Therapeutics|May 25, 2010
Clinical trial: impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn's diseaseS B Hanauer, J Panes, J-F Colombel, et al.
Cancer|November 1, 1981
Disseminated Trichosporon beigelii (cutaneum)C W Yung, S B Hanauer, D Fretzin, et al.
Antimicrobial Agents and Chemotherapy|July 14, 1998
Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, MissouriY Yang, N Bhachech, P A Bradford, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998C Thornsberry, M E Jones, M L Hickey, et al.
Diagnostic Microbiology and Infectious Disease|January 13, 1999
In vitro susceptibility and molecular analysis of gentamicin-resistant enterococciJ W Chow, S M Donabedian, D B Clewell, et al.
Journal of Global Antimicrobial Resistance|November 23, 2016
Antimicrobial resistance and resistance mechanisms of Enterobacteriaceae in ICU and non-ICU wards in Europe and North America: SMART 2011-2013S H Lob, D J Biedenbach, R E Badal, et al.
Cancer|November 1, 1983
Gamma-glutamyltranspeptidase levels as an aid in the management of human cancerD F Sahm, J L Murray, P L Munson, et al.
Obstetrics and Gynecology|July 1, 1990
Comparison of chemiluminescent DNA probe to cell culture for the screening of Chlamydia trachomatis in a gynecology clinic populationL J Mercer, D C Robinson, D F Sahm, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 16, 2002
Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologiesM E Jones, G Gesu, G Ortisi, et al.
Pageof 22